Jump Financial’s Corbus Pharmaceuticals CRBP Stock Holding History

Jump Financial’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$287K	Sell	30,600 -29,700	-49%	-$250K	﹤0.01%	1506
2025 Q4	$491K	Buy	+60,300	New	+$744K	0.01%	1323
2025 Q1	–	Sell	-28,709	Closed	-$339K	–	1644
2024 Q4	$339K	Buy	+28,709	New	+$481K	0.01%	1253
2024 Q3	–	Sell	-12,272	Closed	-$555K	–	1709
2024 Q2	$555K	Buy	+12,272	New	+$516K	0.01%	1093
2022 Q2	–	Sell	-495	Closed	-$8K	–	1676
2022 Q1	$8K	Sell	495 -281	-36%	-$3.72K	﹤0.01%	1498
2021 Q4	$14K	Buy	776 +81	+12%	+$2.19K	﹤0.01%	1333
2021 Q3	$21K	Sell	695 -87	-11%	-$3.43K	﹤0.01%	1046
2021 Q2	$43K	Buy	+782	New	+$43.4K	﹤0.01%	1033

Other funds holding CRBP

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jump Financial's CRBP Position: Q1 2026 in Review

Jump Financial reduced its Corbus Pharmaceuticals (CRBP) stake by 49% in Q1 2026, selling an estimated $250K and leaving 30,600 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #1506.

Jump Financial first reported a position in CRBP in Q2 2021 and has held it in 8 quarters since. The position peaked at $555K in Q2 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

Jump Financial held 30,600 shares of Corbus Pharmaceuticals worth $287K as of Q1 2026.
Jump Financial sold 29,700 Corbus Pharmaceuticals shares in Q1 2026, an estimated $250K.
Corbus Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1506 holding.
Jump Financial first reported a position in Corbus Pharmaceuticals in Q2 2021 and has held it in 8 quarters since.
Jump Financial's Corbus Pharmaceuticals position peaked at $555K in Q2 2024.
107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.